000			01955 a2200541 4500
005			20250517173117.0
264		0	_c20171030
008			201710s 0 0 eng d
022			_a1520-4804
024	7		_a10.1021/acs.jmedchem.7b00462 _2doi
040			_aNLM _beng _cNLM
100	1		_aMould, Daniel P
245	0	0	_aDevelopment of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1. _h[electronic resource]
260			_bJournal of medicinal chemistry _c10 2017
300			_a7984-7999 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xchemical synthesis
650	0	4	_aBiomarkers
650	0	4	_aCell Line, Tumor
650	0	4	_aComputer Simulation
650	0	4	_aDrug Design
650	0	4	_aDrug Discovery
650	0	4	_aEnzyme Inhibitors _xchemical synthesis
650	0	4	_aEther-A-Go-Go Potassium Channels _xdrug effects
650	0	4	_aGlycine _xanalogs & derivatives
650	0	4	_aHigh-Throughput Screening Assays
650	0	4	_aHistone Demethylases _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aLeukemia _xdrug therapy
650	0	4	_aModels, Molecular
650	0	4	_aMolecular Docking Simulation
650	0	4	_aSpiro Compounds _xchemical synthesis
650	0	4	_aStructure-Activity Relationship
650	0	4	_aTranylcypromine _xanalogs & derivatives
700	1		_aAlli, Cristina
700	1		_aBremberg, Ulf
700	1		_aCartic, Sharon
700	1		_aJordan, Allan M
700	1		_aGeitmann, Matthis
700	1		_aMaiques-Diaz, Alba
700	1		_aMcGonagle, Alison E
700	1		_aSomervaille, Tim C P
700	1		_aSpencer, Gary J
700	1		_aTurlais, Fabrice
700	1		_aOgilvie, Donald
773	0		_tJournal of medicinal chemistry _gvol. 60 _gno. 19 _gp. 7984-7999
856	4	0	_uhttps://doi.org/10.1021/acs.jmedchem.7b00462 _zAvailable from publisher's website
999			_c27547699 _d27547699